BACKGROUND Aneurysms affecting the aorta are a common condition associated with high mortality as a result of
and TGFBR2 (5, 6) , the signaling transducer SMAD3 (7), the ligand TGFB2 (8, 9) , and the inhibitor SKI (18, 19) . Probands from families 2 through 8 and 9 through 11 were referred for molecular and/or clinical evaluation to Antwerp (Belgium) or Osaka (Japan), respectively.
Screening of the entire coding region of TGFB3 was performed in 470 additional probands (120 probands had whole-exome sequencing), presenting both with syndromic and nonsyndromic forms of TAAD. The majority of these patients had been screened previously for all known TAAD genes. Family members of mutation-positive patients were ascertained and submitted to clinical investigations.
CENTRAL ILLUSTRATION The Pathway From Patient to Gene and Back
The figure summarizes how initial identification of patients and families, followed by linkage and mutation analysis led to the discovery of TGFB3 mutations. Further exploration of the TGF-b pathway allowed a better phenotypical delineation and characterization that will have implications in personalized clinical management.
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GENOTYPING AND LINKAGE ANALYSIS. Genomic DNA was extracted from peripheral blood samples (Gentra Systems, Qiagen, Hilden, Germany). RNA from 2 patients (1-II:12 and III:11) (Figure 1 ) was extracted from peripheral blood (collected in PAXgene tubes, PreAnalyliX, Qiagen) according to the manufacturer's protocol (PreAnalyliX, Qiagen).
Genome-wide genotyping was conducted using DNA from 6 family members ( Figure 1, family 1) with Illumina Human SNP-Cyto12 Arrays (Illumina, San Diego, California), containing >262,000 genomic HISTOLOGY. Slides were histologically examined after hematoxylin-eosin, Elastica van Gieson (elastin),
Alcian blue (proteoglycans), or Masson's trichrome (collagen) staining using standard techniques.
RESULTS
We studied a large Dutch family (family 1) with clinical features overlapping with MFS and LDS consistent with an autosomal dominant inheritance pattern.
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TGFB3 Mutations Cause Aortic Aneurysms and p.Asn235Metfs*11 (family 9) (Figure 3 ). All Bertoli-Avella et al. messenger RNA (Figures 5D to 5F ).
DISCUSSION
During mouse embryonic development, Tgfb3 is expressed in several tissues, including cardiovascular, pulmonary, skin, and craniofacial structures. 
A check mark indicates presence of the clinical feature, an X indicates absence of the clinical feature, and a question mark indicates presence of a clinical feature is unknown. Joint hypermobility 9
Loeys-Dietz features
Hypertelorism 14
Bifid uvula 11
Cleft palate 5
Values are n, median (range), or n (median; range). *Not all patients were evaluated for all features. †Four aneurysms affected the sinuses of Valsalva, and 2 only affected the ascending aorta. ‡Surgery was performed on 1 patient at age 43 years and 1 at 50 years. §Cerebral, iliac, or subclavian arteries (n ¼ 1 for each location). Bertoli-Avella et al.
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